OR WAIT null SECS
© 2023 MJH Life Sciences and BioPharm International. All rights reserved.
© 2023 MJH Life Sciences™ and BioPharm International. All rights reserved.
Process and plasmid design optimization, disposable equipment, and flexible platform processes all play important roles.
Decreasing vein to vein time saves lives.
The industry revisits the pros and cons of microbial fermentation at scale for biotherapeutics.
September 02, 2022
A predictive modeling approach can offer tighter process control, which can optimize bioreactor output.
August 02, 2022
Successful scale-up and BLA filings for products manufactured by microbial biomanufacturing require strategic planning.
July 02, 2022
Industry adoption of plant-made biologics remains slow, but plant-based technology gains an advantage by mainstream exposure.
June 29, 2022
Under the collaboration, Avantor and GeminiBio will offer custom cGMP solutions to enhance process efficiency and accelerate speed-to-market of novel emerging therapy modalities.
June 27, 2022
MilliporeSigma’s new BioContinuum Seed Train Platform offering enables a fully closed bioprocessing environment for both fed-batch and perfusion N-production.
June 10, 2022
The expansion at Seqirus’ Holly Springs, N.C., manufacturing facility will support the formulation and fill/finish of influenza vaccines.
June 02, 2022
Extensive work has greatly expanded the possibilities for fetal bovine serum sourcing.
May 10, 2022
908 Devices and CPI have formed a collaboration to optimize cell culture media to allow for improved process control.
May 02, 2022
Workforce training is crucial for biopharmaceutical manufacturing.
April 02, 2022
The growing demand for antibody and other bio-therapeutics will require long-term scale-up solutions.